Data as of Apr 17
| +0.02 / +1.63%|
The 2 analysts offering 12-month price forecasts for StemCells Inc have a median target of 2.13, with a high estimate of 2.50 and a low estimate of 1.75. The median estimate represents a +70.00% increase from the last price of 1.25.
The current consensus among 2 polled investment analysts is to Buy stock in StemCells Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.